bimeda (beijing) pharmaceutical technology company limited
Activity value 61china Supplier,Last transaction date:
2025-07-31
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for bimeda (beijing) pharmaceutical technology company limited from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 2 transactions, with a transaction quantity of 6.5 and a transaction weight of 0.
YearTransactionsQuantityWeight
2024000
202526.50
Bill of lading data
<
1/2
>
Trade date
2025/07/31
B/L No.
25nboim008524831
Suppliers
bimeda (beijing) pharmaceutical technology company limited
Buyers
.bimeda ltd.
Product description
250ML DIPEN SUSPENSION FOR INJECTION; 250ML DIPEN SUSPENSION FOR INJECTION; CT; 1; 0.007m3; Dihydrostreptomycin and ProcaineBenzylpenicillin; A; Dihydrostreptomycin and ProcaineBenzylpenicillin; 0;
Expand
Partners
Total 1
RankCompanyTransactionsPerDetail
1.bimeda ltd.
kenyabuyer,they trade on 2025-07-31
2100.00%
>
Products
Total 6
ProductsTransactionsPerDetail
benzylpenicillin 2100%>
dihydrostreptomycin 2100%>
dipe 2100%>
for injection 2100%>
procaine 2100%>
+View All
Hscode rank
Total 0
HSCode NameTransactionsPerDetail
HS 300420002100%>
Trading Area
Total 1
AreaTransactionsPerDetail
kenya2100.00%>
bimeda (beijing) pharmaceutical technology company limited is china Supplier,
and primarily engages in the import and export business of products such as benzylpenicillin,dihydrostreptomycin,dipe.
According to the 52wmb.com global trade database, as of 2025-07-31, the company has completed 2 international trades,
with its main trading regions covering kenya etc.
The core products include HS30042000 etc,
and its main trading partners are .bimeda ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on bimeda (beijing) pharmaceutical technology company limited is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.